In addition, CD38 mAbs can also induce programmed cell death, reduce mitochondrial transfer, inhibit adenosine production and adhesion molecule function, and regulate enzyme activity to cause MM cell death. This evidence concerns the gene CD38 and Miyoshi myopathy.